- 全部删除
- 您的购物车当前为空
Bucillamine (DE019) 可防止高危器官移植中的缺血/再灌注损伤,抑制 VEGF 的产生。 Bucillamine 是一种具有抗风湿和抗血管生成特性的口服活性巯基供体和抗氧化剂。 Bucillamine 可用于脉络膜新生血管和类风湿性关节炎的研究。
为众多的药物研发团队赋能,
让新药发现更简单!
Bucillamine (DE019) 可防止高危器官移植中的缺血/再灌注损伤,抑制 VEGF 的产生。 Bucillamine 是一种具有抗风湿和抗血管生成特性的口服活性巯基供体和抗氧化剂。 Bucillamine 可用于脉络膜新生血管和类风湿性关节炎的研究。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥ 147 | In stock | |
10 mg | ¥ 213 | In stock | |
25 mg | ¥ 347 | In stock | |
50 mg | ¥ 573 | In stock | |
100 mg | ¥ 942 | In stock | |
200 mg | ¥ 1,390 | In stock | |
1 mL x 10 mM (in DMSO) | ¥ 119 | In stock |
Bucillamine 相关产品
产品描述 | Bucillamine (DE019) protects against Ischemia/reperfusion injury in high-risk organ transplants and inhibits the production of VEGF. Bucillamine is an orally active sulfhydryl donor and antioxidant with antirheumatic and antiangiogenic properties. Bucillamine can be used for studies about choroidal neovascularization and rheumatoid arthritis. |
体内活性 | In rats subjected to liver transplants, Bucillamine significantly enhances survival and protected against hepatic injury[2]. Subconjunctival injection of Bucillamine significantly reduces the leakage and size of experimental CNV in rats[3]. |
别名 | 布西拉明, Tiobutarit, Thiobutarit, SA96, DE-019, DE019, DE 019 |
分子量 | 223.31 |
分子式 | C7H13NO3S2 |
CAS No. | 65002-17-7 |
Smiles | [C@@H](NC(C(C)(C)S)=O)(C(O)=O)CS |
密度 | 1.289 g/cm3 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 25 mg/mL (111.95 mM), Sonication is recommended. ![]() | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容